UPDATE - UBS initiates coverage on HCA (HCA) with a Buy; Uncanny Ability to Opportunistically Create Value
Tweet
Share
E-mailGet Alerts HCA Hot Sheet
Price: $407.05 --0%
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 19
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 19
Join SI Premium – FREE
UPDATE - UBS initiates coverage on HCA (NYSE: HCA) with a Buy rating. PT $34.
Analyst, A.J. Rice, said, "With nearly $37 billion in annual revenue, HCA accounts for 4-5% of U.S. hospital revenues. Focused on the faster growing markets of the Sunbelt, HCA controls more than 25% of the hospitals beds in Texas and Florida. Further, HCA enjoys a leading market share position in 14 of the 25 fastest growing metropolitan markets in the U.S."
To see more ratings on HCA, Click Here
Analyst, A.J. Rice, said, "With nearly $37 billion in annual revenue, HCA accounts for 4-5% of U.S. hospital revenues. Focused on the faster growing markets of the Sunbelt, HCA controls more than 25% of the hospitals beds in Texas and Florida. Further, HCA enjoys a leading market share position in 14 of the 25 fastest growing metropolitan markets in the U.S."
To see more ratings on HCA, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts ProQR Therapeutics N.V. (PRQR) at Buy
- Barclays Starts Bitdeer Technologies Group (BTDR) at Overweight
- Jefferies Starts Trekor Metals (TKO:CN) (TGB) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
